Skip to main content

GeneArt Debuts Online Tool to Design, Order 'Low-Price' Synthetic Genes

NEW YORK (GenomeWeb News) — German synthetic genetics company GeneArt will now sell custom genes via an online platform that will allow customers in the “low-price market” to design and order synthetic genes, the company said today.
 
The company said its Mr. Gene tool allows customers to design the genes in a “do-it-yourself” procedure or through a software-assisted procedure. “The new platform gives scientists with small budgets easier access to synthetic genes,” the company said in a statement.
 
GeneArt CFO Christian Ehl said the company launched the service after anticipating strong sales growth in the synthetic genes market. Ehl said the company projects the new service will contribute 25 percent to GeneArt’s sales in the medium term.
 
The company said it expects Mr. Gene to be well suited for the academic market because it offers a low price, but it did not disclose pricing details.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.